Highlights of the 35th European Cystic Fibrosis Conference; Part 1
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Special Edition, Part 1; Dublin Ireland)
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
After participating in this activity, the participant will demonstrate the ability to:
Describe current research that reinforces the need to link CF lung microbiology to clinical outcomes.
Explain when to suspect A. xylosoxidans infection and the evidence basis for effectively treating it.
Evaluate current management tactics for MRSA infections.
Discuss new data that quantifies the damage pulmonary exacerbations cause to CF lungs.
Describe the impact of ivacaftor on lung function, weight gain and BMI in children and adult patients with CF with G551D CFTR mutations.
Peter J. Mogayzel, Jr, MD, PhD, MBA
Associate Professor of Pediatrics
Director, Johns Hopkins University School of Medicine Cystic Fibrosis Center
Stefanie Petrou-Binder, MD
- 1.00 ANCC